Cannabidiol (CBD) is one of the most widely researched cannabinoids found in the cannabis plant. In this 2020 scientific review, researchers examined how CBD interacts with the body and why it is being studied for its potential role in pain management. Unlike THC, CBD does not produce intoxicating effects, but studies suggest it may influence several biological pathways involved in inflammation, pain signaling, and nervous system function. (NCBI)

The review discusses research involving neuropathic pain, inflammatory pain, osteoarthritis, and other pain-related conditions. Researchers found that CBD may affect cannabinoid receptors, serotonin receptors, ion channels, and immune responses that play a role in how pain is processed. The article also highlights evidence suggesting CBD may help regulate inflammatory molecules and reduce pain sensitivity in certain experimental models. (GreenMedInfo)

The authors conclude that CBD shows significant promise as a therapeutic compound, but note that more human clinical research is needed to fully understand its effectiveness, optimal dosing, and long-term safety. As interest in cannabinoid-based therapies continues to grow, CBD remains one of the most actively studied compounds in cannabis research. (GreenMedInfo)

Source: Malek N, Starowicz K. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. International Journal of Molecular Sciences. 2020. Available at: https://pubmed.ncbi.nlm.nih.gov/33238607/